Deep Sequencing Identified Dysregulated Circulating MicroRNAs in Late Onset Preeclampsia

In Vivo. 2020 Sep-Oct;34(5):2317-2324. doi: 10.21873/invivo.12044.

Abstract

Background/aim: To characterize global microRNA (miRNA) expression profile in the first trimester maternal plasma of women who subsequently develop late-onset preeclampsia (LOPE) compared to uncomplicated pregnancies.

Materials and methods: Five first trimester plasma samples from women who developed LOPE and 5 controls were analyzed using next generation sequencing technology (NGS) followed by target prediction, Gene Ontology analysis and pathway identification. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed for confirmation in an independent cohort of 12 LOPE cases and 12 controls.

Results: miR-23b-5p and miR-99b-5p were down-regulated by >1.5 fold in LOPE complicated pregnancies (p value <0.05) compared to controls. Target prediction showed that the major targets of these miRNAs are associated with glycometabolism and immune response.

Conclusion: miR-23b-5p and miR-99b-5p are possibly implicated in the pathogenic mechanisms leading to the induction of LOPE and may serve as candidate non-invasive biomarkers for early prediction and prevention.

Keywords: NGS; late-onset preeclampsia; miR-23b-5p; miR-99b-5p; microRNAs; preeclampsia.

MeSH terms

  • Biomarkers
  • Circulating MicroRNA* / genetics
  • Female
  • Gene Expression Profiling
  • High-Throughput Nucleotide Sequencing
  • Humans
  • MicroRNAs* / genetics
  • Pre-Eclampsia* / diagnosis
  • Pre-Eclampsia* / genetics
  • Pregnancy

Substances

  • Biomarkers
  • Circulating MicroRNA
  • MicroRNAs